Advanced Oncotherapy ups final tranche of fundraise

Advanced Oncotherapy CEO Nicolas Serandour

Advanced Oncotherapy said today that high levels of investor demand had caused it to increase the size of its open offer by 16%. It now expects to raise around £2.9m from the final tranche of its latest equity fundraise through the issue of 7,364,162 new ordinary shares at 40 pence per share. The enlarged offer will…

You must be a HM Subscriber to view this content.

Subscribe Now »